New injection targets skin tumors before surgery in early trial
Disease control
Ongoing
This early-phase trial tests a drug called PH-762, injected directly into skin tumors in people with squamous cell carcinoma, melanoma, or Merkel cell carcinoma. The goal is to see if it is safe and how the body and tumors respond. About 30 participants will receive four weekly i…
Phase: PHASE1 • Sponsor: Phio Pharmaceuticals Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC